SlideShare une entreprise Scribd logo
1  sur  49
Télécharger pour lire hors ligne
The emerging threat posed by carbapenemase producing enterobacteria  &  how to address it Dr. Ashok Rattan Fortis Clinical Research Ltd.
Thienamycin   Streptomyces cattleya   Imipenem   cilastatin Meropenem   Ertapenem   Doripenem   + In 1 : 1 ratio
Spectrum of activity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical Uses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Carabpenemases: a problem in waiting ? David M Livermore & Neil Woodford Current Opinion in Microbiology 2000; 3: 489 - 495 Natural resistance Acquired resistance
Bush 2010 :  Distribution of  β  lactamases according to function Most Carbapenemases can Hydrolyze ALL Beta lactam antibiotics
Carbapenemases ,[object Object],[object Object],[object Object],[object Object],[object Object]
Classification 2d 3 2f Functional Group - - + APBA Inhibition - + - EDTA Inhibition - - + Aztreonam Hydrolysis Serine Zn ++ Serine Active site D B A Molecular Class
Mechanism of Resistance to Carbapenem ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Serine  β   lactamases: Kleb. pneumoniae All  β  lactams USA A KPC Kleb pn. carbapenamase Ps.  Imipenem & extended spectrum cephalosporins French Guiana A GES Guiana Extended spectrum Scotland Europe USA Country Acinetobacter, Ps. Carbapenems (weak) D OXA  Oxacillin hydrolysing Enterobacter spp Carbapenem, aztreonam but not 3 rd  gen cephalosporins A NMC – A, IMI Non metallo carbapenamse Serratia marcescens Carbapenem, aztreonam but not 3 rd  gen cephalosporins A SME Serratia marcesance enzyme Organisms Spectrum of activity Ambler Class Enzyme
Metallo  β  lactamases (Zn at active site) Kleb pneu, E. coli Pan R India, UK B NDM  New Delhi South Korea Germany Brazil Italy Japan Country Acinetobacter, Ps. Pan R B SIM  Souel Ps.  Pan R B GIM  German Ps Pan R B SPM Sao Paulo Ps. , Acinetobacter Pan R, may be S to  aztreonam B VIM (12) Verona Ps., Acinetobacter All  β  lactams B IMP (18) Imipenem Japan Organisms Spectrum of activity Ambler Class Enzyme
March of Carbapenemases Lancet Infect Dis  2010; 10: 597–602  Published  Online  August 11, 2010 1985 1986 1990 1995 2000   2008  2010 Imipenem  launched Chromosomal  R  in Ps IMP in  Japan VIM in  Verona KPC in  USA NDM 1 Clinical Microbiology and Infection, Volume 16 Number 12, December 2010 Castanheira M et al: Anti Agents Chem 2010 SENTRY Program Out of 39 strains collected from India in 2006 15 strains had NDM 1 10 strains carried OXA 48 variant 2 strains carried VIM 6 Multiple PFGE patterns
 
 
 
Location of Bla KPC  gene
Why is CRE a public health emergency ? ,[object Object],[object Object],[object Object],[object Object]
Why is CRE spreading ? ,[object Object],[object Object],[object Object],[object Object]
Who is infected with CRE ? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Recommendations for control ,[object Object],[object Object],[object Object]
Surveillance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infection Control CDC’s recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infection control: add ons Kochar S et al. Infect control & Hosp Epidemiol 2009; 30: 447 - 452 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Laboratory Detection Clinical and Laboratory Standards Institute breakpoints: 2009 & 2010 Revised Break Points 2010 < 15  < 19 16-18  20-22 19-21 >  22  > 23 > 8 > 1 4 0.5 2 <  1 <  0.25 ERT < 13  < 19 14-15  20-22 16-21 > 22  > 23 > 16 > 4 8 2 2-4 <  1 <  1 MEM < 13 < 19 14-15 20-22 NA > 16 > 23 > 16 > 4 8 2 2-4 <  1 <  1 IPM R I MHT S R I MHT S DD breakpoints (mm) MIC breakpoint (ug/ml) Agent
 
 
Screening for CRE
Screening for CRE carriage Sample  Select  Differentiate TSB + carbapenem disk
CHROMagar ESBL & KPC Panagea T et al : Evaluation of CHROMagar TM  KPC for the detection of  carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. International JournalofAntimicrobialAgents xxx (2010) xxx–xxx  Randall LP et al: Evaluation of CHROMagar CTX, a novel medium for isolating  CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.  Journal of Antimicrobial Chemotherapy (2009) 63, 302–308
Test for Carbapenemase Detection Anderson KF et al. Evaluation of methods to identify KPC in enterobacteriaceae. JCM 2007; 45: 2723 – 2725. ,[object Object],[object Object],Carbapenem Disk Susceptible  E. coli Test Isolate
Double Disk Picao RC et al: MBL detection: Double Disk Synergy vs Combined Disk. JCM 2008; 46: 2028 - 2037
Combined Disk Doi Y et al. Single disk method for detecting KPC by use of a  Boronic acid compound. JCM 2008; 46: 4083 - 4086
E test Walsh T et al. Evaluation of a new Etest for detecting MLB in routine clinical testing. JCM 2002; 40: 2755 - 2759
Pasteran F et al. Controlling false positive results in MHT..  JCM 2010; 48: 1323 - 1332
Pasteran F et al. Controlling false positive results in MHT..  JCM 2010; 48: 1323 - 1332
Pasteran F et al. Controlling false positive results in MHT..  JCM 2010; 48: 1323 - 1332 False Positive
MASUDA  ASSAY
Phenotypic Detection N N N OXA Y N N MBL N Y N KPC N Y Y Amp C N N N ESBL Inhibited by Cloxacillin  Boronic acid  EDTA/DPA Enzyme
Sensitivity & specificity of  phenotypic methods 77 100 Carbapenemase Modified Hodge 80 100 MBL EDTA 100 100 MBL DPA 100 80 Amp C APBA+ CLX 98 100 KPC APBA Specificity Sensitivity β   lactamase Test
Genotypic detection of CRE Mendes RE et al: RT PCR for MBL JCM 2007; 45: 544 - 547
Naaz T et al: Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases  and KPC Carbapenemases. Anti Agents Chemother 2010; 54: 3086 - 3092
Detecting CRE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae 2010 Dutch Working Party on the Detection of Highly Resistant Microorganisms Clinical isolates
Algorithm for disk diffusion synergy tests to detect C arbapenem  N on  S usceptible  E nterobacteriaceae APBA = aminophenyl boronic acid ( β  lactamase inhibitor) DPA  = dipicolinic acid (metal chelating agent)
Epidemiological scale & stage of nationwide expansion of CNSE Areas of Improvement ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Carry Home messages ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Would respond  to treatment with A carbapenem
We may not be able to stop the  emergence of Super bugs  but we CAN

Contenu connexe

Tendances

Laboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaLaboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaMostafa Mahmoud
 
Drug resistance mechanism & their detection, recent advances
Drug resistance mechanism & their detection, recent advancesDrug resistance mechanism & their detection, recent advances
Drug resistance mechanism & their detection, recent advancesDr. Kanwal Deep Singh Lyall
 
LECTURES SERIES ESBLs
LECTURES SERIES ESBLsLECTURES SERIES ESBLs
LECTURES SERIES ESBLsNuhu Tanko
 
Acinetobacter baumannii
Acinetobacter baumanniiAcinetobacter baumannii
Acinetobacter baumanniiJake Hunter
 
Carbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care UnitCarbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care UnitYazan Kherallah
 
Development of strategies for management of infections with carbapenem resist...
Development of strategies for management of infections with carbapenem resist...Development of strategies for management of infections with carbapenem resist...
Development of strategies for management of infections with carbapenem resist...Bhoj Raj Singh
 
ESBL: From petri dish to patient
ESBL: From petri dish to patientESBL: From petri dish to patient
ESBL: From petri dish to patientPathKind Labs
 
Inducible Clindamycin Resistance Test
Inducible Clindamycin Resistance TestInducible Clindamycin Resistance Test
Inducible Clindamycin Resistance TestDr. Samira Fattah
 
beta lactamases : structure , classification and investigations
beta lactamases : structure , classification and investigationsbeta lactamases : structure , classification and investigations
beta lactamases : structure , classification and investigationsDr Taoufik Djerboua
 
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...Abdullatif Al-Rashed
 
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPCAIIMS, New Delhi, India
 
Antimicrobial Resistance - Hemant Kanase
Antimicrobial Resistance - Hemant KanaseAntimicrobial Resistance - Hemant Kanase
Antimicrobial Resistance - Hemant KanaseHemant Kanase
 

Tendances (20)

Laboratory detection of resistant bacteria
Laboratory detection of resistant bacteriaLaboratory detection of resistant bacteria
Laboratory detection of resistant bacteria
 
Drug resistance mechanism & their detection, recent advances
Drug resistance mechanism & their detection, recent advancesDrug resistance mechanism & their detection, recent advances
Drug resistance mechanism & their detection, recent advances
 
Drug resistant gram - ve bacteria by Dr.T.V.Rao MD
Drug resistant gram - ve bacteria by Dr.T.V.Rao MDDrug resistant gram - ve bacteria by Dr.T.V.Rao MD
Drug resistant gram - ve bacteria by Dr.T.V.Rao MD
 
LECTURES SERIES ESBLs
LECTURES SERIES ESBLsLECTURES SERIES ESBLs
LECTURES SERIES ESBLs
 
Acinetobater infection Updated Medical Microbiological View
Acinetobater infection Updated Medical Microbiological View Acinetobater infection Updated Medical Microbiological View
Acinetobater infection Updated Medical Microbiological View
 
MRSA Detection
MRSA DetectionMRSA Detection
MRSA Detection
 
Acinetobacter baumannii
Acinetobacter baumanniiAcinetobacter baumannii
Acinetobacter baumannii
 
Susceptibility 2023
Susceptibility 2023Susceptibility 2023
Susceptibility 2023
 
Carbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care UnitCarbapenamases in the Intensive Care Unit
Carbapenamases in the Intensive Care Unit
 
Development of strategies for management of infections with carbapenem resist...
Development of strategies for management of infections with carbapenem resist...Development of strategies for management of infections with carbapenem resist...
Development of strategies for management of infections with carbapenem resist...
 
ESBL Detection
ESBL DetectionESBL Detection
ESBL Detection
 
Drug resistant gram - ve bacteria
Drug resistant gram -  ve bacteriaDrug resistant gram -  ve bacteria
Drug resistant gram - ve bacteria
 
Acinetobacter baumannii an update
Acinetobacter baumannii an update Acinetobacter baumannii an update
Acinetobacter baumannii an update
 
ESBL: From petri dish to patient
ESBL: From petri dish to patientESBL: From petri dish to patient
ESBL: From petri dish to patient
 
Inducible Clindamycin Resistance Test
Inducible Clindamycin Resistance TestInducible Clindamycin Resistance Test
Inducible Clindamycin Resistance Test
 
beta lactamases : structure , classification and investigations
beta lactamases : structure , classification and investigationsbeta lactamases : structure , classification and investigations
beta lactamases : structure , classification and investigations
 
Amp C
Amp CAmp C
Amp C
 
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...
Best Practice for Colistin Susceptibility Testing: Methods and Evidence (Mini...
 
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
Specific Multi-drug Resistance MRSA-VRSA-ESBL-KPC
 
Antimicrobial Resistance - Hemant Kanase
Antimicrobial Resistance - Hemant KanaseAntimicrobial Resistance - Hemant Kanase
Antimicrobial Resistance - Hemant Kanase
 

En vedette

Carbapenemase NDM em não-baumannii na China
Carbapenemase NDM em não-baumannii na ChinaCarbapenemase NDM em não-baumannii na China
Carbapenemase NDM em não-baumannii na ChinaIvson Cassiano
 
Community acquired pneumonia 2015 part 2
Community acquired pneumonia  2015  part 2Community acquired pneumonia  2015  part 2
Community acquired pneumonia 2015 part 2samirelansary
 
Zika virus infection
Zika virus infectionZika virus infection
Zika virus infectionHelen Madamba
 
Poster Presentation-FINAL
Poster Presentation-FINALPoster Presentation-FINAL
Poster Presentation-FINALKevin Knight
 
Rapid Catch Indicators Lunch Roundtable_10.12.12
Rapid Catch Indicators Lunch Roundtable_10.12.12Rapid Catch Indicators Lunch Roundtable_10.12.12
Rapid Catch Indicators Lunch Roundtable_10.12.12CORE Group
 
Superbug Infection | Dr Jose Poulose
Superbug Infection | Dr Jose PouloseSuperbug Infection | Dr Jose Poulose
Superbug Infection | Dr Jose PouloseDr. Jose Poulose
 
Zika Virus infection ( disease )
Zika Virus infection ( disease )Zika Virus infection ( disease )
Zika Virus infection ( disease )D.A.B.M
 
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...RajabAmr
 
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...João Marcos
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Rakesh Kumar
 
KPC (Klebsiella pneumoniae carbapenamases)
KPC (Klebsiella pneumoniae carbapenamases)KPC (Klebsiella pneumoniae carbapenamases)
KPC (Klebsiella pneumoniae carbapenamases)Malithi Weerakkody
 

En vedette (20)

Carbapenemase NDM em não-baumannii na China
Carbapenemase NDM em não-baumannii na ChinaCarbapenemase NDM em não-baumannii na China
Carbapenemase NDM em não-baumannii na China
 
Cap
CapCap
Cap
 
Gene Therapy
Gene TherapyGene Therapy
Gene Therapy
 
Cap2015
Cap2015Cap2015
Cap2015
 
Community acquired pneumonia 2015 part 2
Community acquired pneumonia  2015  part 2Community acquired pneumonia  2015  part 2
Community acquired pneumonia 2015 part 2
 
Carbapenemases
CarbapenemasesCarbapenemases
Carbapenemases
 
Zika virus infection
Zika virus infectionZika virus infection
Zika virus infection
 
Poster Presentation-FINAL
Poster Presentation-FINALPoster Presentation-FINAL
Poster Presentation-FINAL
 
Rapid Catch Indicators Lunch Roundtable_10.12.12
Rapid Catch Indicators Lunch Roundtable_10.12.12Rapid Catch Indicators Lunch Roundtable_10.12.12
Rapid Catch Indicators Lunch Roundtable_10.12.12
 
You and kpc
You and kpcYou and kpc
You and kpc
 
Ebp Vap
Ebp VapEbp Vap
Ebp Vap
 
Superbug Infection | Dr Jose Poulose
Superbug Infection | Dr Jose PouloseSuperbug Infection | Dr Jose Poulose
Superbug Infection | Dr Jose Poulose
 
Zika Virus infection ( disease )
Zika Virus infection ( disease )Zika Virus infection ( disease )
Zika Virus infection ( disease )
 
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...
Ten-Color, 14 Antibody Flow cytometry (FCM) Screening Tube for Lymphoprolifer...
 
NDM-1 SUPERBUG
NDM-1 SUPERBUGNDM-1 SUPERBUG
NDM-1 SUPERBUG
 
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...
Métodos de detecção de resistência bacteriana aos antimicrobianos em bacilos ...
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)
 
Homocystinuria
HomocystinuriaHomocystinuria
Homocystinuria
 
KPC (Klebsiella pneumoniae carbapenamases)
KPC (Klebsiella pneumoniae carbapenamases)KPC (Klebsiella pneumoniae carbapenamases)
KPC (Klebsiella pneumoniae carbapenamases)
 
Kpc hr presentation 2011
Kpc hr presentation 2011Kpc hr presentation 2011
Kpc hr presentation 2011
 

Similaire à Carbapenemase 2011

Mdr Xdr Tb What Microbiologist Should Know Iamm 2009
Mdr Xdr Tb What Microbiologist Should Know Iamm 2009Mdr Xdr Tb What Microbiologist Should Know Iamm 2009
Mdr Xdr Tb What Microbiologist Should Know Iamm 2009PathKind Labs
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany Elshamy
 
advances in head neck cancers.pptx
advances in head neck cancers.pptxadvances in head neck cancers.pptx
advances in head neck cancers.pptxShahidShaikh615046
 
Tacking the menage of gram negative inf with novel bl bli.pptx
Tacking the menage of gram negative inf with novel bl bli.pptxTacking the menage of gram negative inf with novel bl bli.pptx
Tacking the menage of gram negative inf with novel bl bli.pptxaceforum
 
ESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfFarah Fara
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPnavinthakkar
 
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity ACT antimicrobial susceptibility testing, inoculation and drug sensitivity
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity Arsh Gull
 
H A P&amp; V A P
H A P&amp; V A PH A P&amp; V A P
H A P&amp; V A PMed Bee
 
Anti tubercular therapy in Skeletal TB
Anti tubercular therapy in Skeletal TBAnti tubercular therapy in Skeletal TB
Anti tubercular therapy in Skeletal TBNeelaBiradar
 
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...WAidid
 
GU ASCO 2023 Targeted Therapy in mCRPC.pptx
GU ASCO 2023 Targeted Therapy in mCRPC.pptxGU ASCO 2023 Targeted Therapy in mCRPC.pptx
GU ASCO 2023 Targeted Therapy in mCRPC.pptxDoQuyenPhan1
 
Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUVitrag Shah
 

Similaire à Carbapenemase 2011 (20)

Tuberculosis diagnostics
Tuberculosis diagnosticsTuberculosis diagnostics
Tuberculosis diagnostics
 
Management of Multidrug Resstiant Bacterial Infections management fortis 27....
Management of Multidrug Resstiant Bacterial Infections  management fortis 27....Management of Multidrug Resstiant Bacterial Infections  management fortis 27....
Management of Multidrug Resstiant Bacterial Infections management fortis 27....
 
ICAAC 2013: Resumen
ICAAC 2013: ResumenICAAC 2013: Resumen
ICAAC 2013: Resumen
 
Mdr Xdr Tb What Microbiologist Should Know Iamm 2009
Mdr Xdr Tb What Microbiologist Should Know Iamm 2009Mdr Xdr Tb What Microbiologist Should Know Iamm 2009
Mdr Xdr Tb What Microbiologist Should Know Iamm 2009
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide results
 
advances in head neck cancers.pptx
advances in head neck cancers.pptxadvances in head neck cancers.pptx
advances in head neck cancers.pptx
 
Tacking the menage of gram negative inf with novel bl bli.pptx
Tacking the menage of gram negative inf with novel bl bli.pptxTacking the menage of gram negative inf with novel bl bli.pptx
Tacking the menage of gram negative inf with novel bl bli.pptx
 
CRPC management
CRPC managementCRPC management
CRPC management
 
220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf220614-FEMS-2022-TmpSmx_final.pdf
220614-FEMS-2022-TmpSmx_final.pdf
 
ESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdfESMO Oesophageal cancer webinar.pdf
ESMO Oesophageal cancer webinar.pdf
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCP
 
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity ACT antimicrobial susceptibility testing, inoculation and drug sensitivity
ACT antimicrobial susceptibility testing, inoculation and drug sensitivity
 
ICN Victoria: Cornely on "Being a Fun-gi in ICU"
ICN Victoria: Cornely on "Being a Fun-gi in ICU"ICN Victoria: Cornely on "Being a Fun-gi in ICU"
ICN Victoria: Cornely on "Being a Fun-gi in ICU"
 
H A P&amp; V A P
H A P&amp; V A PH A P&amp; V A P
H A P&amp; V A P
 
Anti tubercular therapy in Skeletal TB
Anti tubercular therapy in Skeletal TBAnti tubercular therapy in Skeletal TB
Anti tubercular therapy in Skeletal TB
 
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
Managing Community-acquired Pneumonia and Hospital-acquired Pneumonia - Profe...
 
GU ASCO 2023 Targeted Therapy in mCRPC.pptx
GU ASCO 2023 Targeted Therapy in mCRPC.pptxGU ASCO 2023 Targeted Therapy in mCRPC.pptx
GU ASCO 2023 Targeted Therapy in mCRPC.pptx
 
HAP VAP CHALLENGES
HAP VAP CHALLENGESHAP VAP CHALLENGES
HAP VAP CHALLENGES
 
Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICU
 
Mdr tuberculosis updates
Mdr tuberculosis updatesMdr tuberculosis updates
Mdr tuberculosis updates
 

Plus de PathKind Labs

iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptxPathKind Labs
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxPathKind Labs
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxPathKind Labs
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxPathKind Labs
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxPathKind Labs
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptxPathKind Labs
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxPathKind Labs
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxPathKind Labs
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxPathKind Labs
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic usePathKind Labs
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19PathKind Labs
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortPathKind Labs
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tbPathKind Labs
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosisPathKind Labs
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosisPathKind Labs
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesPathKind Labs
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsPathKind Labs
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and howPathKind Labs
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 shortPathKind Labs
 

Plus de PathKind Labs (20)

iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptx
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptx
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptx
 
iso 15189.pptx
iso 15189.pptxiso 15189.pptx
iso 15189.pptx
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptx
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptx
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptx
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptx
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic use
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose short
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosis
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosis
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinations
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and how
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 short
 

Dernier

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 

Dernier (20)

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 

Carbapenemase 2011

  • 1. The emerging threat posed by carbapenemase producing enterobacteria & how to address it Dr. Ashok Rattan Fortis Clinical Research Ltd.
  • 2. Thienamycin Streptomyces cattleya Imipenem cilastatin Meropenem Ertapenem Doripenem + In 1 : 1 ratio
  • 3.
  • 4.
  • 5.
  • 6. Carabpenemases: a problem in waiting ? David M Livermore & Neil Woodford Current Opinion in Microbiology 2000; 3: 489 - 495 Natural resistance Acquired resistance
  • 7. Bush 2010 : Distribution of β lactamases according to function Most Carbapenemases can Hydrolyze ALL Beta lactam antibiotics
  • 8.
  • 9. Classification 2d 3 2f Functional Group - - + APBA Inhibition - + - EDTA Inhibition - - + Aztreonam Hydrolysis Serine Zn ++ Serine Active site D B A Molecular Class
  • 10.
  • 11. Serine β lactamases: Kleb. pneumoniae All β lactams USA A KPC Kleb pn. carbapenamase Ps. Imipenem & extended spectrum cephalosporins French Guiana A GES Guiana Extended spectrum Scotland Europe USA Country Acinetobacter, Ps. Carbapenems (weak) D OXA Oxacillin hydrolysing Enterobacter spp Carbapenem, aztreonam but not 3 rd gen cephalosporins A NMC – A, IMI Non metallo carbapenamse Serratia marcescens Carbapenem, aztreonam but not 3 rd gen cephalosporins A SME Serratia marcesance enzyme Organisms Spectrum of activity Ambler Class Enzyme
  • 12. Metallo β lactamases (Zn at active site) Kleb pneu, E. coli Pan R India, UK B NDM New Delhi South Korea Germany Brazil Italy Japan Country Acinetobacter, Ps. Pan R B SIM Souel Ps. Pan R B GIM German Ps Pan R B SPM Sao Paulo Ps. , Acinetobacter Pan R, may be S to aztreonam B VIM (12) Verona Ps., Acinetobacter All β lactams B IMP (18) Imipenem Japan Organisms Spectrum of activity Ambler Class Enzyme
  • 13. March of Carbapenemases Lancet Infect Dis 2010; 10: 597–602 Published Online August 11, 2010 1985 1986 1990 1995 2000 2008 2010 Imipenem launched Chromosomal R in Ps IMP in Japan VIM in Verona KPC in USA NDM 1 Clinical Microbiology and Infection, Volume 16 Number 12, December 2010 Castanheira M et al: Anti Agents Chem 2010 SENTRY Program Out of 39 strains collected from India in 2006 15 strains had NDM 1 10 strains carried OXA 48 variant 2 strains carried VIM 6 Multiple PFGE patterns
  • 14.  
  • 15.  
  • 16.  
  • 17. Location of Bla KPC gene
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Laboratory Detection Clinical and Laboratory Standards Institute breakpoints: 2009 & 2010 Revised Break Points 2010 < 15 < 19 16-18 20-22 19-21 > 22 > 23 > 8 > 1 4 0.5 2 < 1 < 0.25 ERT < 13 < 19 14-15 20-22 16-21 > 22 > 23 > 16 > 4 8 2 2-4 < 1 < 1 MEM < 13 < 19 14-15 20-22 NA > 16 > 23 > 16 > 4 8 2 2-4 < 1 < 1 IPM R I MHT S R I MHT S DD breakpoints (mm) MIC breakpoint (ug/ml) Agent
  • 26.  
  • 27.  
  • 29. Screening for CRE carriage Sample Select Differentiate TSB + carbapenem disk
  • 30. CHROMagar ESBL & KPC Panagea T et al : Evaluation of CHROMagar TM KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. International JournalofAntimicrobialAgents xxx (2010) xxx–xxx Randall LP et al: Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains. Journal of Antimicrobial Chemotherapy (2009) 63, 302–308
  • 31.
  • 32. Double Disk Picao RC et al: MBL detection: Double Disk Synergy vs Combined Disk. JCM 2008; 46: 2028 - 2037
  • 33. Combined Disk Doi Y et al. Single disk method for detecting KPC by use of a Boronic acid compound. JCM 2008; 46: 4083 - 4086
  • 34. E test Walsh T et al. Evaluation of a new Etest for detecting MLB in routine clinical testing. JCM 2002; 40: 2755 - 2759
  • 35. Pasteran F et al. Controlling false positive results in MHT.. JCM 2010; 48: 1323 - 1332
  • 36. Pasteran F et al. Controlling false positive results in MHT.. JCM 2010; 48: 1323 - 1332
  • 37. Pasteran F et al. Controlling false positive results in MHT.. JCM 2010; 48: 1323 - 1332 False Positive
  • 39. Phenotypic Detection N N N OXA Y N N MBL N Y N KPC N Y Y Amp C N N N ESBL Inhibited by Cloxacillin Boronic acid EDTA/DPA Enzyme
  • 40. Sensitivity & specificity of phenotypic methods 77 100 Carbapenemase Modified Hodge 80 100 MBL EDTA 100 100 MBL DPA 100 80 Amp C APBA+ CLX 98 100 KPC APBA Specificity Sensitivity β lactamase Test
  • 41. Genotypic detection of CRE Mendes RE et al: RT PCR for MBL JCM 2007; 45: 544 - 547
  • 42. Naaz T et al: Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and KPC Carbapenemases. Anti Agents Chemother 2010; 54: 3086 - 3092
  • 43.
  • 44. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae 2010 Dutch Working Party on the Detection of Highly Resistant Microorganisms Clinical isolates
  • 45. Algorithm for disk diffusion synergy tests to detect C arbapenem N on S usceptible E nterobacteriaceae APBA = aminophenyl boronic acid ( β lactamase inhibitor) DPA = dipicolinic acid (metal chelating agent)
  • 46.
  • 47.
  • 48.
  • 49. We may not be able to stop the emergence of Super bugs but we CAN